Index
1 Market Overview of Hospital-acquired infections (HAIs) Control
1.1 Hospital-acquired infections (HAIs) Control Market Overview
1.1.1 Hospital-acquired infections (HAIs) Control Product Scope
1.1.2 Hospital-acquired infections (HAIs) Control Market Status and Outlook
1.2 Global Hospital-acquired infections (HAIs) Control Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hospital-acquired infections (HAIs) Control Market Size by Region (2018-2029)
1.4 Global Hospital-acquired infections (HAIs) Control Historic Market Size by Region (2018-2023)
1.5 Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hospital-acquired infections (HAIs) Control Market Size (2018-2029)
1.6.1 North America Hospital-acquired infections (HAIs) Control Market Size (2018-2029)
1.6.2 Europe Hospital-acquired infections (HAIs) Control Market Size (2018-2029)
1.6.3 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size (2018-2029)
1.6.4 Latin America Hospital-acquired infections (HAIs) Control Market Size (2018-2029)
1.6.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size (2018-2029)
2 Hospital-acquired infections (HAIs) Control Market by Type
2.1 Introduction
2.1.1 Diagnostic techniques
2.1.2 Dleaning and sterilization
2.1.3 Treatment
2.2 Global Hospital-acquired infections (HAIs) Control Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hospital-acquired infections (HAIs) Control Historic Market Size by Type (2018-2023)
2.2.2 Global Hospital-acquired infections (HAIs) Control Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hospital-acquired infections (HAIs) Control Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hospital-acquired infections (HAIs) Control Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hospital-acquired infections (HAIs) Control Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hospital-acquired infections (HAIs) Control Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hospital-acquired infections (HAIs) Control Revenue Breakdown by Type (2018-2029)
3 Hospital-acquired infections (HAIs) Control Market Overview by Application
3.1 Introduction
3.1.1 General Hospital
3.1.2 Infectious Disease Hospital
3.2 Global Hospital-acquired infections (HAIs) Control Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hospital-acquired infections (HAIs) Control Historic Market Size by Application (2018-2023)
3.2.2 Global Hospital-acquired infections (HAIs) Control Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hospital-acquired infections (HAIs) Control Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hospital-acquired infections (HAIs) Control Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hospital-acquired infections (HAIs) Control Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hospital-acquired infections (HAIs) Control Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hospital-acquired infections (HAIs) Control Revenue Breakdown by Application (2018-2029)
4 Hospital-acquired infections (HAIs) Control Competition Analysis by Players
4.1 Global Hospital-acquired infections (HAIs) Control Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hospital-acquired infections (HAIs) Control as of 2022)
4.3 Date of Key Players Enter into Hospital-acquired infections (HAIs) Control Market
4.4 Global Top Players Hospital-acquired infections (HAIs) Control Headquarters and Area Served
4.5 Key Players Hospital-acquired infections (HAIs) Control Product Solution and Service
4.6 Competitive Status
4.6.1 Hospital-acquired infections (HAIs) Control Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 STERIS Corporation
5.1.1 STERIS Corporation Profile
5.1.2 STERIS Corporation Main Business
5.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Products, Services and Solutions
5.1.4 STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue (US$ Million) & (2018-2023)
5.1.5 STERIS Corporation Recent Developments
5.2 Advanced Sterilization Products Division
5.2.1 Advanced Sterilization Products Division Profile
5.2.2 Advanced Sterilization Products Division Main Business
5.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Products, Services and Solutions
5.2.4 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue (US$ Million) & (2018-2023)
5.2.5 Advanced Sterilization Products Division Recent Developments
5.3 Hoffmann-La Roche
5.3.1 Hoffmann-La Roche Profile
5.3.2 Hoffmann-La Roche Main Business
5.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Products, Services and Solutions
5.3.4 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Hospital-acquired infections (HAIs) Control Products, Services and Solutions
5.4.4 Pfizer Hospital-acquired infections (HAIs) Control Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Becton Dickinson
5.5.1 Becton Dickinson Profile
5.5.2 Becton Dickinson Main Business
5.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Products, Services and Solutions
5.5.4 Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue (US$ Million) & (2018-2023)
5.5.5 Becton Dickinson Recent Developments
6 North America
6.1 North America Hospital-acquired infections (HAIs) Control Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hospital-acquired infections (HAIs) Control Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hospital-acquired infections (HAIs) Control Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hospital-acquired infections (HAIs) Control Market Dynamics
11.1 Hospital-acquired infections (HAIs) Control Industry Trends
11.2 Hospital-acquired infections (HAIs) Control Market Drivers
11.3 Hospital-acquired infections (HAIs) Control Market Challenges
11.4 Hospital-acquired infections (HAIs) Control Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List